Clinical significance of decreased or loss of ABO blood group expression in acute myeloid leukaemia: A single-centre retrospective study.
Jay Ho HanHowon LeeJae Kwon KimJaeeun YooKyuho ParkDong Wook JekarlYonggoo KimPublished in: Vox sanguinis (2024)
AML with decreased expression or loss of ABO blood group showed better early survival during D90. Transfusion support for this subgroup of AML patients should be meticulously performed considering serum typing.
Keyphrases
- acute myeloid leukemia
- poor prognosis
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- binding protein
- bone marrow
- dendritic cells
- randomized controlled trial
- hepatitis b virus
- drug induced
- intensive care unit
- clinical trial
- patient reported
- free survival
- sickle cell disease
- genetic diversity
- acute respiratory distress syndrome
- placebo controlled